66 related articles for article (PubMed ID: 15093808)
21. Synthesis, (18)F-labeling, and biological evaluation of piperidyl and pyrrolidyl benzilates as in vivo ligands for muscarinic acetylcholine receptors.
Skaddan MB; Kilbourn MR; Snyder SE; Sherman PS; Desmond TJ; Frey KA
J Med Chem; 2000 Nov; 43(23):4552-62. PubMed ID: 11087580
[TBL] [Abstract][Full Text] [Related]
22. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
[TBL] [Abstract][Full Text] [Related]
23. In vitro and ex vivo evaluation of cyclic aminoalkyl benzilates as potential emission tomography ligands for the muscarinic receptor.
Otto CA; Mulholland GK; Perry SE; Combs R; Sherman PS; Fisher SJ
Int J Rad Appl Instrum B; 1989; 16(1):51-5. PubMed ID: 2785511
[TBL] [Abstract][Full Text] [Related]
24. Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.
Honer M; Brühlmeier M; Missimer J; Schubiger AP; Ametamey SM
J Nucl Med; 2004 Mar; 45(3):464-70. PubMed ID: 15001689
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.
Kumar JS; Prabhakaran J; Erlandsson K; Majo VJ; Simpson NR; Pratap M; Van Heertum RL; Mann JJ; Parsey RV
Nucl Med Biol; 2006 May; 33(4):565-74. PubMed ID: 16720250
[TBL] [Abstract][Full Text] [Related]
26. Influence of acetylcholine levels on the binding of a SPECT nicotinic acetylcholine receptor ligand [123I]5-I-A-85380.
Fujita M; Al-Tikriti MS; Tamagnan G; Zoghbi SS; Bozkurt A; Baldwin RM; Innis RB
Synapse; 2003 Jun; 48(3):116-22. PubMed ID: 12645036
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2 alpha-tropanyl benzilate: a central muscarinic receptor imaging agent.
Mulholland GK; Otto CA; Jewett DM; Kilbourn MR; Koeppe RA; Sherman PS; Petry NA; Carey JE; Atkinson ER; Archer S
J Nucl Med; 1992 Mar; 33(3):423-30. PubMed ID: 1740713
[TBL] [Abstract][Full Text] [Related]
28. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
[TBL] [Abstract][Full Text] [Related]
29. The role of species-dependent metabolism in the regional brain retention of 18F-labeled muscarinic acetylcholine receptor ligands.
Skaddan MB; Sherman PS; Kilbourn MR
Nucl Med Biol; 2001 Oct; 28(7):753-9. PubMed ID: 11578895
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter.
Giboureau N; Emond P; Fulton RR; Henderson DJ; Chalon S; Garreau L; Roselt P; Eberl S; Mavel S; Bodard S; Fulham MJ; Guilloteau D; Kassiou M
Synapse; 2007 Dec; 61(12):962-70. PubMed ID: 17787004
[TBL] [Abstract][Full Text] [Related]
32. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
[TBL] [Abstract][Full Text] [Related]
33. [11C]SMe-ADAM, an imaging agent for the brain serotonin transporter: synthesis, pharmacological characterization and microPET studies in rats.
Zessin J; Deuther-Conrad W; Kretzschmar M; Wüst F; Pawelke B; Brust P; Steinbach J; Bergmann R
Nucl Med Biol; 2006 Jan; 33(1):53-63. PubMed ID: 16459259
[TBL] [Abstract][Full Text] [Related]
34. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
[TBL] [Abstract][Full Text] [Related]
35. Modulation of acetylcholine release by nicotinic receptors in the rat brain.
De Sarno P; Giacobini E
J Neurosci Res; 1989 Feb; 22(2):194-200. PubMed ID: 2709442
[TBL] [Abstract][Full Text] [Related]
36. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding.
Zubieta JK; Koeppe RA; Mulholland GK; Kuhl DE; Frey KA
J Cereb Blood Flow Metab; 1998 Jun; 18(6):619-31. PubMed ID: 9626186
[TBL] [Abstract][Full Text] [Related]
37. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
Easwaramoorthy B; Pichika R; Collins D; Potkin SG; Leslie FM; Mukherjee J
Synapse; 2007 Jan; 61(1):29-36. PubMed ID: 17068780
[TBL] [Abstract][Full Text] [Related]
38. In vivo visualization of acetylcholinesterase with positron emission tomography.
Tavitian B; Pappata S; Planas AM; Jobert A; Bonnot-Lours S; Crouzel C; DiGiamberardino L
Neuroreport; 1993 May; 4(5):535-8. PubMed ID: 8513134
[TBL] [Abstract][Full Text] [Related]
39. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
40. SPET imaging of central muscarinic receptors with (R,R)[123I]-I-QNB: methodological considerations.
Norbury R; Travis MJ; Erlandsson K; Waddington W; Owens J; Ell PJ; Murphy DG
Nucl Med Biol; 2004 Jul; 31(5):583-90. PubMed ID: 15219276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
